🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.
UPGRADE TO SEE LIVE SIGNALS
$EDIT
Editas Medicine Inc
FREE PREVIEW
AVG HISTORICAL GAP2.70%
MAX GAP RECORD15.58%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY4.1%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL